View all staff
Doctor Fay Chinnery

Dr Fay Chinnery

Research Fellow (Health Tech Assmt&Mod)

Connect with Fay

Email: F.Chinnery@soton.ac.uk

ORCID
Publications Biography
Publications Biography

Publications

18 publications
Page 1 of 2
Bevacizumab gamma for treating wet age-related macular degeneration
Jonathan Shepherd, Fay Chinnery, Emma Maund, David Alexander Scott & Joanne Lord, 2024
Type: report
Enfortumab vedotin with pembrolizumab for first-line treatment of unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy [ID6332]
Emma Maund, Fay Chinnery, Keith Cooper & Jonathan Shepherd, 2024
Type: report
Efgartigimod for treating generalised myasthenia gravis
Fay Chinnery, Lois Woods, Keith Cooper, Bogdan Grigore, David Alexander Scott & Joanna Picot, 2023
Type: report
Bimekizumab for treating active psoriatic arthritis
David Alexander Scott, Karen Pickett, Keith Cooper, Fay Chinnery & Joanna Picot, 2023
Type: report
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
Lorna Hazell, Keith Cooper, Fay Chinnery, Karen Pickett, David Alexander Scott & Jonathan Shepherd, 2023
Type: report
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial
Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew Mcmillan, Peter Johnson & Gareth Griffiths, 2022, F1000Research, 9
DOI: 10.12688/f1000research.22318.1
Type: article
Nintedanib for treating idiopathic pulmonary fibrosis in people with a forced vital capacity above 80% predicted (part-review of technology appraisal guidance 379)
Keith Cooper, Lorna Hazell, Asyl Hawa, Joanna Picot, Fay Chinnery, David Alexander Scott & Jonathan Shepherd, 2022
Type: report
Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women
Susanne Renz, Fay Chinnery, Beth Stuart, Laura Day, Ingrid Muller, Irene Soulsby, Jacqui Nuttall, Karen Thomas, Kim Suzanne Thomas, Tracey Sach, Louise Stanton, Matthew J Ridd, Nick Francis, Paul Little, Zina Eminton, Gareth Griffiths, Alison M Layton & Miriam Santer, 2021, BMJ Open, 11(8)
DOI: 10.1136/bmjopen-2021-053876
Type: article
A phase 2 open-label study of carboplatin in combination with gemcitabine as a dose-dense schedule in patients with locally advanced or metastatic breast cancer that are resistant to anthracyclines and taxanes
Andrew Davies, Christopher Mansbridge, Peter Simmonds, Nicholas Murray, Louise Stanton, Fay Chinnery, Caroline Archer, Peter Barrett-Lee, Tamas Hickish & Simon Crabb, 2020, F1000 Research
Type: article
Evaluation of stakeholder views on peer review of NIHR applications for funding
Sheila Turner, Abby Bull, Fay Chinnery, Jeremy Hinks, Nicola McArdle, Rebecca Moran, Helen Payne, Eleanor Woodford Guegan, Louise Worswick & Jeremy C. Wyatt, 2018, BMJ Open, 8(12)
DOI: 10.1136/bmjopen-2018-022548
Type: article